Feb 28, 2020
Outlook into the Antimicrobial Susceptibility Testing Market to 2027 - Drivers, Restraints, Opportunities and Challenges
Feb 28, 2020
Outlook into the Antimicrobial Susceptibility Testing Market to 2027 - Drivers, Restraints, Opportunities and Challenges
Feb 28, 2020
Outlook into the Antimicrobial Susceptibility Testing Market to 2027 - Drivers, Restraints, Opportunities and Challenges
Feb 19, 2020
Antibacterial Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025
Feb 14, 2020
Veterinary Antibiotics Market Trends Report 2020 - Increasing Collaboration Between Companies
Feb 12, 2020
FDA Grants Plasmology4® "Breakthrough Device Designation" for the Treatment of Multidrug-Refractory Bacteria
Feb 10, 2020
Researchers at Ben-Gurion University Introduce Platform for the Design of New Antibiotics
Feb 04, 2020
Citius Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
Jan 30, 2020
The Antimicrobial Crisis: New Antibiotics Could Avert 230,000 Deaths Per Year
Jan 27, 2020
At IPPE, EW Nutrition Tackles Antimicrobial Resistance With Functional Solutions
Jan 15, 2020
Acurx Receives USAN Approval of Non-proprietary Name Ibezapolstat for Its Phase 2 Novel, First-in-Class Antibiotic for C. difficile Infection
Jan 09, 2020
Phagelux to Present at Biotech Showcase 2020 in San Francisco
Jan 09, 2020
Gladskin Launches in USA - Micreos Scaling up to Deliver Award Winning Technology Worldwide
Jan 08, 2020
Adaptive Phage Therapeutics Awarded Initial Contract with Department of Defense
Jan 07, 2020
Synthetic Biologics Receives FDA Guidance at Type C Meeting for SYN-004 (ribaxamase) Phase 1b/2a Clinical Trial in Allogeneic HCT Recipients
Jan 06, 2020
Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update
Dec 19, 2019
Superbug-Inactivating Emitters From Bolb Inc. Poised to Lower Healthcare Costs and Enhance Food Safety
Dec 05, 2019
Sharklet, a biomimetic antibacterial and antifouling technology, launched at the "Old Man and The Sea: A Sneak Peek into the Future"
Dec 04, 2019
Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill 'Superbugs' as Part of Bear's Den Innovation Program
Nov 21, 2019
Syngulon and Eppen sign a MOU for the development of a new generation of feed probiotics leveraging bacteriocins as a natural alternative to antibiotics